Research notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

New Haven!

Acusensus
3:27pm
October 7, 2025
ACE’s automated speed enforcement win with the Connecticut department of Transport (US$22.6m) is ACE’s largest US contract win to date and a significant proof-point in the US market, which remains a material opportunity for the group over the coming years. With the group progressing alternative bank funding options, we believe it remains in a solid position to deliver growth with improved funding flexibility, de-risking near-term requirements for further capital. Factoring in ACE’s US contract win along with an increase to market-based multiples in our blended valuation sees our price target lift to $2.05 (from $1.30/sh)

FY25 result preview

Bank of Queensland
3:27pm
October 7, 2025
We preview BOQ’s FY25 result scheduled for release next week. Key headline earnings have been pre-disclosed, but trends in underlying drivers will be important for forecasts of future years. We downgrade forecast earnings due to gross loan declines below what we had previously anticipated combined with the fixed cost leverage. 12 month target price downgraded to $6.20/s. At current prices we estimate potential total return of -9%. Hence, we continue to recommend retain a TRIM rating.

Playing defence

VEEM
3:27pm
October 7, 2025
VEE’s 9-year supply agreement with Northrop Grumman marks a major milestone, following its recent approval as a Level 1 supplier to HII-NNS. These agreements position VEE to provide equipment to two of the most prominent prime contractors in the US defence sector. VEE’s $14m capital raise will enhance its capacity to pursue further growth opportunities in the defence sector. Post-raise, pro forma net debt is expected to reduce to ~$0.6m compared to $13.7m at the end of FY25. Despite the strong momentum in defence, management noted that slower-than-expected conversion of gyro leads into orders and a delayed ramp-up in ASC orders means 1H26 EBITDA is expected to be slightly below 1H25. However, revenue is expected to accelerate in 2H26. We decrease our FY26 EBITDA forecast by 13% but increase our estimates for both FY27 and FY28 by 2% mainly on increased growth assumptions for defence. Our target price rises to $1.66 (from $1.30), reflecting upgrades to our outer-year earnings forecasts due to greater confidence in VEE’s ability to secure additional defence contracts, and a roll-forward of our model. We view further contract announcements as potential positive catalysts for the stock. With a 12-month forecast TSR of 14%, we move our rating to ACCUMULATE (from BUY).

Gold-copper asset rich

Sunstone Metals
3:27pm
October 7, 2025
Sunstone Metals (ASX:STM) reports a resource to JORC Code (2012) standards of 2.7Moz gold equivalent (AuEq - 1.8Moz Au and 378Mlb Cu) at Bramaderos, southern Ecuador (STM 87.5%), part of a much larger Exploration Target including the Limon epithermals and deeper gold-copper finger porphyries. At El Palmar, 60km north-west of the Ecuadorean capital Quito, Sunstone has identified five porphyry copper-gold targets extending from surface with an initial resource to JORC Code (2012) standards of 1.2Moz AuEq (800koz gold, 1.3Moz silver, 176Mlb copper) in one of these. Gold is trading above US$3,800/oz, up 90% over the past year, The share prices of ASX-listed gold producers have lifted, with the World’s largest gold miner, Newmont (ASX:NEM) up over 60% over the year. Our assessment is that share price appreciation for juniors with gold resources but no cashflow has yet to reflect this gold price strength across the board.

The wait is finally over

Neurizon Therapeutics
3:27pm
October 6, 2025
The FDA has finally lifted the clinical hold on NUZ-001 after 9 months, clearing the way for NUZ to join the HEALEY ALS Platform Trial and removing a major regulatory overhang. First patient enrolment in the HEALEY trial is targeted by the end of the year, with initial data possible by late 2026 depending on recruitment rates. This is a major catalyst and a clear regulatory de-risking event for NUZ. With a validated IND and a clear path into HEALEY, we expect renewed investor interest and momentum in the stock as the company advances towards trial and data. Our target price moderates to A$0.39 and we maintain our Speculative Buy rating.

Positive news continues; Rover contract and CT grant

Micro-X
3:27pm
October 3, 2025
MX1 continues to make solid progress across all its verticals. Today MX1 announced its largest contract for its Rover Plus worth A$3.3m. Other recent announcements note positive progress on the Head CT imaging project with the ASA, a A$4.4m grant to trial the head CT scanner in standard ambulances for stroke diagnosis and a contract extension with the DHS to enhance the self-screening checkpoint detection algorithm. We have made no changes to forecasts or valuation of A$0.17. The cadence of newsflow increases our confidence that MX1 has reached an important inflection point and deserves greater investor attention. We maintain our SPECULATIVE BUY recommendation.

Cycle strengthens

ALS Limited
3:27pm
October 3, 2025
Exploration activity is poised to accelerate. Our proprietary raisings data indicates that geochemistry sample volumes will be trending up +20-30% in November which will be a key positive catalyst for the stock. Despite a sharp rise in volumes, we forecast FY26 Commodities revenue to grow +12% (from +10%) as price lags volume and downstream (metallurgy) lags upstream (geochemistry). In FY27, we forecast +20% revenue growth in Commodities (from +12%). This sees our FY26 NPAT forecast largely unchanged (+1-2%) but our FY27-28 forecasts rise by +7-8%. Our target price increases to $24.60 (from $20.00).

Successful playbook turns to Fertiliser opportunity

Ridley Corporation
3:27pm
October 3, 2025
RIC produces premium quality, high performance animal nutrition products. Its recent acquisition of Incitec Pivot Fertilisers (IPF) distribution business has now transformed RIC into a leading diversified Australian agricultural services provider. Similar initiatives that successfully turned around the base RIC business over the last few years can now be applied to IPF, underpinning solid earnings growth. Despite strong share price appreciation since announcing the acquisition of IPF, we are positive on the group’s future prospects and initiate coverage with an Accumulate rating and A$3.25 price target.

Offshore partnerships takes the opportunity up a gear

Eagers Automotive
3:27pm
October 3, 2025
APE has executed on two highly strategic transactions: 1) taking a majority interest (65%) in CanadaOne Auto; and 2) Mitsubishi Corporation acquiring 20% of EA132. As part of the transactions, APE is conducting an underwritten entitlement offer (to raise A$452m) and Mitsubishi is investing A$50m in APE via a placement. The combined deals are ~15% EPS accretive (on LTM financials to June-25). APE’s opportunity set has expanded, with the business having levers for a material earnings step-up over time across: domestic franchise auto (market share and margin); Canadian auto retail (significant market share opportunity); Independent used (global opportunities); and ancillary opportunities (enabled by scale).

Strength in numbers

New Hope Group
3:27pm
October 2, 2025
NHC delivered increased production through FY25, reduced its FOB costs, and maintained both a high dividend yield and a strong net cash position, reinforcing its operational discipline and financial resilience. NHC’s strengthening production profile is underpinned by low-cost, high-margin, long-life assets. We think that thermal coal pricing has found its natural floor and that NHC offers a resilient, high-quality exposure to the next coal price cycle. NHC looks cheap, but does suit patient/ value investors, particularly as catalysts for thermal coal look limited in the short term. We rate NHC an ACCUMULATE with a target price of A$4.35ps.

News & insights

Explore Michael Knox’s November 2025 economic outlook: global growth trends, Australian inflation, interest rates, commodities, and equity insights.

Quarterly Economic Outlook – November 2025

Michael Knox, Morgans Chief Economist, shares his latest quarterly outlook on global growth, inflation, commodities, and interest rates. Here are the key takeaways for November 2025.

Global Growth Outlook

Growth is slowing but stabilising across major economies:

  • US: Eases to 1.8% in 2025 (including effects of US shutdown), recovering to 2.2% in 2026.
  • Euro Area: Improves to 1.2% in 2025.
  • China: Slows to 4.8%.
  • India: Strong at 6.6%.
  • Australia: Firms to 1.9%, inflation at 3.5%.
Global GDP & Inflation Table

Australia: Inflation & Employment

  • Retail electricity prices are rising as subsidies end, adding pressure to inflation.
  • Employment growth is soft at 1.5%, below the median of 2.17%.
  • Unemployment near 4% suggests inflation around 3.4%, above the RBA target.

Electricity Price Chart
Australian Employment Growth
Unemployment vs Inflation

Interest Rates & Monetary Policy

  • RBA cash rate expected to rise to 4.1%, driven by higher core inflation.
  • In the US, below-trend growth signals potential Fed Funds rate cuts ahead.

Australian Cash Rate Model
Chicago Fed Activity Index

Commodities Snapshot

  • Iron Ore: Slightly above fair value at US$100.80.
  • Copper: Significantly overvalued at US$10,225 per tonne.
  • Nickel & Zinc: Moderately undervalued.
  • Gold: At record highs (US$4,013 per ounce) with limited upside.
  • Soft Commodities: Wheat and cotton remain undervalued, presenting potential buying opportunities.

Gold Price Model

Equities Outlook

  • S&P500: Model suggests fair value above current levels, but earnings expected to ease in Q4.
  • ASX200: Trading well above model estimates, indicating strong sentiment.

S&P500 Model
ASX200 Model

Currency & Bonds

  • AUD/USD: Model estimate at US70.94 cents, above current level of US65.48 cents.
  • US and German bonds appear moderately overvalued, reflecting strong foreign buying.

AUD/USD Model

Closing Thoughts

Global growth is slowing, but commodity markets and equities show mixed signals. Inflation pressures in Australia suggest further rate hikes, while US policy may ease. Investors should watch undervalued opportunities in soft commodities and monitor interest rate trends closely.

FAQs

1. What is the outlook for global economic growth in 2025?

Global growth is slowing but stabilising. The US is expected to grow at 1.8%, the Euro Area at 1.2%, China at 4.8%, India at 6.6%, and Australia at 1.9%.

2. Why is Australian inflation expected to remain high?

Inflation pressures are driven by rising retail electricity prices as subsidies end, combined with relatively strong demand and employment trends.

3. Will the Reserve Bank of Australia raise interest rates?

Yes, the RBA cash rate is forecast to rise to around 4.1% in response to higher core inflation.

4. Which commodities are currently undervalued?

Soft commodities like wheat and cotton are significantly undervalued, while iron ore is near fair value and copper remains overvalued.

5. How are equity markets positioned heading into 2026?

The S&P500 is trading below model estimates, suggesting potential upside, while the ASX200 is above fair value, reflecting strong investor sentiment.

DISCLAIMER: Information is of a general nature only. Before making any financial decisions, you should consult with an experienced professional to obtain advice specific to your circumstances.

Read more
A detailed comparison of US productivity and global growth forecasts, highlighting key differences with Australia.

Why The US Has Higher Productivity

Good morning. Today I want to talk about the U.S. economy in comparison, to other economies and, why it's performing, the way it is. The documents I will refer to are first the IMF, outlook, which is,  come out in the last two weeks.  That gives us some international comparisons.

For the US economy I use, the monthly outlook from Standard and Poor's, which is, the number one rated by the Congressional Budget Office, well ahead of other economic forecasters. For the US economy, both the IMF and, Standard Poor's agree that growth this year should be 2%. Our own model of the US economy, based on the Chicago Fed National Activity Indicator, is also forcasting US growth of 2%.

Still, that's 2% is less whatever the negative effect is from, from the US shutdown. When the shutdown continues for a month, that growth rate falls from 2% down to about 1.8 % 1.7%. So it's a moderate slowdown. Still growth in the U.S. economy accelerates next year to about 2.2%. I'll talk later on where that growth is coming from.

When we look at growth in other areas we see that: Euro area is miserable. Great Britain is growing faster than the Euro area now. This year the UK should grow by 1.3% but, the Euro area should grow by about 1.2% this year. Euro area growth drifts off to an even more miserable 1.1% next year. But fortunately, that generates a lot of savings to invest in other countries like us. Those savings then go in to the US equities and bond markets and, the Australian stock market and places like that.

China is slowing down to 4.8% this year and 4.2% next year according to the, IMF. Still, heroically India, marches on to 6.6% growth this year and 6.2% next year. For emerging markets, which include the Indo Pacific generally ,Growth is proceeding  at about 5.2% this year and 4.7%, next year.

The U.S is still, pretty good in comparison. This year, it's, growing at 2% or, depending on  the results of the shutdown. Next US Growth accelerates, to 2.2%, and growth is then about the same the year after.

There's been a lot of debate this year about the effect of tariffs on the US inflation.  In spite of higher tariffs , US inflation is stubbornly , stubbornly low. Headline inflation, which includes food and energy this year should be only 2.8%. Hardly something to scare markets. And that continues a 2.9% next year and 2.5% the year after. Amazingly,US  core inflation is a bit higher than that 3% this year and 3.3% next year. It's just that food and energy prices are falling in the US. Why can't that happen here?

Lets look at one of the reasons that you get really quite steady growth and relatively low inflation in the US The comparison I want to make here is between US output per hour and Australian output per hour. In the beginning of this year, we had a shocking slowdown in productivity growth because our government decided that was better to hire more, people from the public service than generate employment in the private sector. It is well known that, productivity in the market economy grows much faster than in the, than in the public sector. So,  for the first quarter, productivity in Australia grew, or  output per hour worked per annum ,grew by 0.3%  . The RBA has told us that, they expect output per hour that will rise to about 0.7%per annum , the same as the UK. And we'll be able to maintain productivity growth rate of 0.7%, going forward.

Let's compare that to what's happening in the US economy. This year It looks like the US will be producing labour productivity much higher than the Australia.  US Output per hour should grow by 1.6% this year . Next year US Output per hour may grow  even more by, 2.1%. Following that US labour productivity the year should grow between 1.6 and 1.7%,. This is  full 1% faster than, the Australian economy is expected to grow in terms of productivity. Remember, it's growth and productivity which generates increase in living standards.

There's two reasons, that we can provide for why the U.S., productivity is growing so much faster than ours. One is a flexible labour market. It's an extremely flexible labour market in the US. The current Australian government has made our labour market less flexible, less than it previously was. A second reason is deregulation . The program of deregulation by the US administration is making it easier for business , to do business.

That, of course, in turn generates higher levels of business investment. That higher level of business investments creates more growth. So, it's a series of policies which are different in each country . The result will be that, living standards in, in the U.S are going to start going to be growing significantly faster than they are in Australia.

And that's the end of the good news for the day.

Read more
Australia's trimmed mean inflation hit 3%, driven by surging electricity prices and the end of federal subsidies, signalling the end of the rate-cut cycle.

Last time I spoke to you about Australian inflation and its effect on what the RBA might do in its November meeting, I said that expectations for inflation for the year to September, which would be published in October, were between 2.5% and 2.7%. I also said that if inflation came in at the lower estimate of 2.5%, then we could see a rate cut in November.

Well, the numbers are out, and unfortunately, not only are we not getting a rate cut in November, it’s unlikely we’ll see another rate cut any time soon. In fact, it’s fair to say we may be at the very end of the rate-cutting cycle in Australia. The reason is that the core measure, the trimmed mean, which is the RBA’s preferred measure of underlying inflation, came in not at 2.5%, not at 2.6%, and not even at 2.7%, but at a shockingly high 3%.

This result was driven by a 1.3% increase in prices in the previous quarter, which annualises to about 5%, a surprise that wasn’t anticipated. Looking deeper into the quarterly CPI, we saw housing prices rising at 4.7%, health costs up 4.2%, and education costs increasing by 5.3%.

The ABS has indicated that the major source of inflation was a jump in goods inflation, which rose 3%, up 1.1% from the previous quarter, or 4.4% annualised. The standout contributor was electricity, which saw a massive year-on-year increase of 23.6%. Other household fuels actually fell by 1.6%, and annual services inflation was 3.5%.

The ABS attributed this unexpected rise in inflation primarily to electricity prices. But it’s not just electricity prices themselves, it’s the end of Federal Government funding to the states that had been keeping those prices low.

The ABS reported that electricity prices rose 23.6% over the past 12 months, largely because State Government rebates, funded by the Commonwealth under the Energy Bill Relief Fund, have now been used up. These rebates included Queensland’s $1,000 rebate, Western Australia’s $400 rebate, and Tasmania’s $250 rebate. With these rebates exhausted, electricity prices have surged.

The A

BS data shows electricity prices excluding government rebates, and highlights the impact of the federal funding. Electricity prices really took off in 2023, rising by almost 20%, which posed a political risk for the Federal Government. In response, the Government provided funding to State Governments to suppress those prices. There were schemes in both 2023 and 2024, and ahead of the last election, the subsidised price paid by consumers dropped to around 80% of the original cost, well below the actual cost of generation.

However, since December 2024, those subsidies have been reduced. Over the past year, prices have climbed again, though they remain below the unsubsidised cost, which is now around 122% of the original price, or about a quarter higher than where things stood in 2023.

The result of all this is 3% core inflation. If inflation had come in at 2.5%, rates could have fallen from 3.6% to 3.35%. But with 3% core inflation, rates should need to rise by 25 basis points. That said, we’re likely at the end of the rate-cut cycle.

Is the RBA likely to raise rates? They might consider it, but this is cost-push inflation, not demand-driven inflation, so increasing rates wouldn’t help. It would only worsen the situation. This very high inflation figure, driven by the end of federal electricity subsidies, signals the end of the current series of Australian rate cuts.

Read more